Loading…
Prenatally buprenorphine-exposed children: health to 3 years of age
Our prospective study is among the first attempts to examine the health of prenatally buprenorphine-exposed children after neonatal age and to determine the types of child maltreatment in this patient group. The study population included 102 children (61/41 Caucasian males/females) who had a positiv...
Saved in:
Published in: | European journal of pediatrics 2015-11, Vol.174 (11), p.1525-1533 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c405t-c701b82459fe12b5bb12e90c029819972a4e8eacdd2cbf2e2da67cce33e682b03 |
---|---|
cites | cdi_FETCH-LOGICAL-c405t-c701b82459fe12b5bb12e90c029819972a4e8eacdd2cbf2e2da67cce33e682b03 |
container_end_page | 1533 |
container_issue | 11 |
container_start_page | 1525 |
container_title | European journal of pediatrics |
container_volume | 174 |
creator | Kivistö, Kaisa Tupola, Sarimari Kivitie-Kallio, Satu |
description | Our prospective study is among the first attempts to examine the health of prenatally buprenorphine-exposed children after neonatal age and to determine the types of child maltreatment in this patient group. The study population included 102 children (61/41 Caucasian males/females) who had a positive urine screen for buprenorphine as a newborn. In addition to buprenorphine, the children were also prenatally exposed to other substances. The data were collected by pediatricians in follow-up visits until 3 years of age and from medical records. Ten prenatally buprenorphine-exposed children (10 %) had some birth defect. The study children had slightly more major anomalies than newborns on average in Finland (3.4 %). Eye disorders (nystagmus, opticus atrophy, and strabismus) occurred in 11 % of children. One child was diagnosed with hepatitis C transmission. One female died of sudden infant death syndrome (SIDS), and one male died of congenital heart disease. Pediatricians submitted altogether 70 reports to child welfare services of suspected maltreatment. Of these reports, 45 (64 %) involved medical neglect. Physical abuse was suspected in four reports.
Conclusion
: We suggest that prenatally buprenorphine-exposed children have several types of problems with their health at toddler age and that they are susceptible to child maltreatment, especially to medical neglect.
What is Known:
•
Buprenorphine is used in the treatment of opioid addiction in pregnancy. Prenatally buprenorphine-exposed newborns develop neonatal abstinence syndrome (NAS) in about 60 % of cases. Data on the health and maltreatment of these children after neonatal age are limited.
What is New:
•
Prenatally buprenorphine-exposed children can have several types of problems with their physical health by 3 years of age, and they are susceptible to child maltreatment, especially to medical neglect. |
doi_str_mv | 10.1007/s00431-015-2562-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1728258398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1728258398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-c701b82459fe12b5bb12e90c029819972a4e8eacdd2cbf2e2da67cce33e682b03</originalsourceid><addsrcrecordid>eNp1kMtKxDAUhoMozjj6AG6k4MZN9CTpJXEn4xUEXeg6pOnpXOi0NWnBeRufxSczZUYRwVVI8p3__HyEHDM4ZwDZhQeIBaPAEsqTlFPYIWMWC04ZZOkuGYOIgaZMqRE58H4JYUYxuU9GPAUQaaLG5PrZYW06U1XrKO_bcGlcO1_USPG9bTwWkZ0vqiK8X0ZzNFU3j7omEp8fazTOR00ZmRkekr3SVB6PtueEvN7evEzv6ePT3cP06pHaGJKO2gxYLnmcqBIZz5M8ZxwVWOBKhpIZNzFKNLYouM1LjrwwaWYtCoGp5DmICTnb5LaueevRd3q18BarytTY9F6zjEueSKFkQE__oMumd3VoN1BZooSELFBsQ1nXeO-w1K1brIxbawZ6UKw3inVQrAfFeihxsk3u8xUWPxPfTgPAN4APX_UM3a_V_6Z-AUzjhiQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1727593807</pqid></control><display><type>article</type><title>Prenatally buprenorphine-exposed children: health to 3 years of age</title><source>Springer Link</source><creator>Kivistö, Kaisa ; Tupola, Sarimari ; Kivitie-Kallio, Satu</creator><creatorcontrib>Kivistö, Kaisa ; Tupola, Sarimari ; Kivitie-Kallio, Satu</creatorcontrib><description>Our prospective study is among the first attempts to examine the health of prenatally buprenorphine-exposed children after neonatal age and to determine the types of child maltreatment in this patient group. The study population included 102 children (61/41 Caucasian males/females) who had a positive urine screen for buprenorphine as a newborn. In addition to buprenorphine, the children were also prenatally exposed to other substances. The data were collected by pediatricians in follow-up visits until 3 years of age and from medical records. Ten prenatally buprenorphine-exposed children (10 %) had some birth defect. The study children had slightly more major anomalies than newborns on average in Finland (3.4 %). Eye disorders (nystagmus, opticus atrophy, and strabismus) occurred in 11 % of children. One child was diagnosed with hepatitis C transmission. One female died of sudden infant death syndrome (SIDS), and one male died of congenital heart disease. Pediatricians submitted altogether 70 reports to child welfare services of suspected maltreatment. Of these reports, 45 (64 %) involved medical neglect. Physical abuse was suspected in four reports.
Conclusion
: We suggest that prenatally buprenorphine-exposed children have several types of problems with their health at toddler age and that they are susceptible to child maltreatment, especially to medical neglect.
What is Known:
•
Buprenorphine is used in the treatment of opioid addiction in pregnancy. Prenatally buprenorphine-exposed newborns develop neonatal abstinence syndrome (NAS) in about 60 % of cases. Data on the health and maltreatment of these children after neonatal age are limited.
What is New:
•
Prenatally buprenorphine-exposed children can have several types of problems with their physical health by 3 years of age, and they are susceptible to child maltreatment, especially to medical neglect.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s00431-015-2562-0</identifier><identifier>PMID: 26003659</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Age ; Alcohol ; Analgesics, Opioid - adverse effects ; Buprenorphine - adverse effects ; Child ; Child abuse & neglect ; Child Abuse - diagnosis ; Child, Preschool ; Children & youth ; Congenital diseases ; Diabetes ; Drug abuse ; Female ; Finland - epidemiology ; Health Status ; Hepatitis B ; Hepatitis C ; Heroin ; Hospitals ; Humans ; Immune system ; Infant ; Infant, Newborn ; Infections ; Male ; Males ; Medical records ; Medicine ; Medicine & Public Health ; Methadone ; Mothers ; Narcotics ; Neonatal abstinence syndrome ; Original Article ; Pediatrics ; Pregnancy ; Prenatal Exposure Delayed Effects - chemically induced ; Prenatal Exposure Delayed Effects - epidemiology ; Prospective Studies ; SIDS ; Substance abuse treatment ; Sudden infant death syndrome ; Urine ; White people</subject><ispartof>European journal of pediatrics, 2015-11, Vol.174 (11), p.1525-1533</ispartof><rights>Springer-Verlag Berlin Heidelberg 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-c701b82459fe12b5bb12e90c029819972a4e8eacdd2cbf2e2da67cce33e682b03</citedby><cites>FETCH-LOGICAL-c405t-c701b82459fe12b5bb12e90c029819972a4e8eacdd2cbf2e2da67cce33e682b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26003659$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kivistö, Kaisa</creatorcontrib><creatorcontrib>Tupola, Sarimari</creatorcontrib><creatorcontrib>Kivitie-Kallio, Satu</creatorcontrib><title>Prenatally buprenorphine-exposed children: health to 3 years of age</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><addtitle>Eur J Pediatr</addtitle><description>Our prospective study is among the first attempts to examine the health of prenatally buprenorphine-exposed children after neonatal age and to determine the types of child maltreatment in this patient group. The study population included 102 children (61/41 Caucasian males/females) who had a positive urine screen for buprenorphine as a newborn. In addition to buprenorphine, the children were also prenatally exposed to other substances. The data were collected by pediatricians in follow-up visits until 3 years of age and from medical records. Ten prenatally buprenorphine-exposed children (10 %) had some birth defect. The study children had slightly more major anomalies than newborns on average in Finland (3.4 %). Eye disorders (nystagmus, opticus atrophy, and strabismus) occurred in 11 % of children. One child was diagnosed with hepatitis C transmission. One female died of sudden infant death syndrome (SIDS), and one male died of congenital heart disease. Pediatricians submitted altogether 70 reports to child welfare services of suspected maltreatment. Of these reports, 45 (64 %) involved medical neglect. Physical abuse was suspected in four reports.
Conclusion
: We suggest that prenatally buprenorphine-exposed children have several types of problems with their health at toddler age and that they are susceptible to child maltreatment, especially to medical neglect.
What is Known:
•
Buprenorphine is used in the treatment of opioid addiction in pregnancy. Prenatally buprenorphine-exposed newborns develop neonatal abstinence syndrome (NAS) in about 60 % of cases. Data on the health and maltreatment of these children after neonatal age are limited.
What is New:
•
Prenatally buprenorphine-exposed children can have several types of problems with their physical health by 3 years of age, and they are susceptible to child maltreatment, especially to medical neglect.</description><subject>Age</subject><subject>Alcohol</subject><subject>Analgesics, Opioid - adverse effects</subject><subject>Buprenorphine - adverse effects</subject><subject>Child</subject><subject>Child abuse & neglect</subject><subject>Child Abuse - diagnosis</subject><subject>Child, Preschool</subject><subject>Children & youth</subject><subject>Congenital diseases</subject><subject>Diabetes</subject><subject>Drug abuse</subject><subject>Female</subject><subject>Finland - epidemiology</subject><subject>Health Status</subject><subject>Hepatitis B</subject><subject>Hepatitis C</subject><subject>Heroin</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Immune system</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Male</subject><subject>Males</subject><subject>Medical records</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methadone</subject><subject>Mothers</subject><subject>Narcotics</subject><subject>Neonatal abstinence syndrome</subject><subject>Original Article</subject><subject>Pediatrics</subject><subject>Pregnancy</subject><subject>Prenatal Exposure Delayed Effects - chemically induced</subject><subject>Prenatal Exposure Delayed Effects - epidemiology</subject><subject>Prospective Studies</subject><subject>SIDS</subject><subject>Substance abuse treatment</subject><subject>Sudden infant death syndrome</subject><subject>Urine</subject><subject>White people</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKxDAUhoMozjj6AG6k4MZN9CTpJXEn4xUEXeg6pOnpXOi0NWnBeRufxSczZUYRwVVI8p3__HyEHDM4ZwDZhQeIBaPAEsqTlFPYIWMWC04ZZOkuGYOIgaZMqRE58H4JYUYxuU9GPAUQaaLG5PrZYW06U1XrKO_bcGlcO1_USPG9bTwWkZ0vqiK8X0ZzNFU3j7omEp8fazTOR00ZmRkekr3SVB6PtueEvN7evEzv6ePT3cP06pHaGJKO2gxYLnmcqBIZz5M8ZxwVWOBKhpIZNzFKNLYouM1LjrwwaWYtCoGp5DmICTnb5LaueevRd3q18BarytTY9F6zjEueSKFkQE__oMumd3VoN1BZooSELFBsQ1nXeO-w1K1brIxbawZ6UKw3inVQrAfFeihxsk3u8xUWPxPfTgPAN4APX_UM3a_V_6Z-AUzjhiQ</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Kivistö, Kaisa</creator><creator>Tupola, Sarimari</creator><creator>Kivitie-Kallio, Satu</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20151101</creationdate><title>Prenatally buprenorphine-exposed children: health to 3 years of age</title><author>Kivistö, Kaisa ; Tupola, Sarimari ; Kivitie-Kallio, Satu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-c701b82459fe12b5bb12e90c029819972a4e8eacdd2cbf2e2da67cce33e682b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Age</topic><topic>Alcohol</topic><topic>Analgesics, Opioid - adverse effects</topic><topic>Buprenorphine - adverse effects</topic><topic>Child</topic><topic>Child abuse & neglect</topic><topic>Child Abuse - diagnosis</topic><topic>Child, Preschool</topic><topic>Children & youth</topic><topic>Congenital diseases</topic><topic>Diabetes</topic><topic>Drug abuse</topic><topic>Female</topic><topic>Finland - epidemiology</topic><topic>Health Status</topic><topic>Hepatitis B</topic><topic>Hepatitis C</topic><topic>Heroin</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Immune system</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Male</topic><topic>Males</topic><topic>Medical records</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methadone</topic><topic>Mothers</topic><topic>Narcotics</topic><topic>Neonatal abstinence syndrome</topic><topic>Original Article</topic><topic>Pediatrics</topic><topic>Pregnancy</topic><topic>Prenatal Exposure Delayed Effects - chemically induced</topic><topic>Prenatal Exposure Delayed Effects - epidemiology</topic><topic>Prospective Studies</topic><topic>SIDS</topic><topic>Substance abuse treatment</topic><topic>Sudden infant death syndrome</topic><topic>Urine</topic><topic>White people</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kivistö, Kaisa</creatorcontrib><creatorcontrib>Tupola, Sarimari</creatorcontrib><creatorcontrib>Kivitie-Kallio, Satu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kivistö, Kaisa</au><au>Tupola, Sarimari</au><au>Kivitie-Kallio, Satu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prenatally buprenorphine-exposed children: health to 3 years of age</atitle><jtitle>European journal of pediatrics</jtitle><stitle>Eur J Pediatr</stitle><addtitle>Eur J Pediatr</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>174</volume><issue>11</issue><spage>1525</spage><epage>1533</epage><pages>1525-1533</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><abstract>Our prospective study is among the first attempts to examine the health of prenatally buprenorphine-exposed children after neonatal age and to determine the types of child maltreatment in this patient group. The study population included 102 children (61/41 Caucasian males/females) who had a positive urine screen for buprenorphine as a newborn. In addition to buprenorphine, the children were also prenatally exposed to other substances. The data were collected by pediatricians in follow-up visits until 3 years of age and from medical records. Ten prenatally buprenorphine-exposed children (10 %) had some birth defect. The study children had slightly more major anomalies than newborns on average in Finland (3.4 %). Eye disorders (nystagmus, opticus atrophy, and strabismus) occurred in 11 % of children. One child was diagnosed with hepatitis C transmission. One female died of sudden infant death syndrome (SIDS), and one male died of congenital heart disease. Pediatricians submitted altogether 70 reports to child welfare services of suspected maltreatment. Of these reports, 45 (64 %) involved medical neglect. Physical abuse was suspected in four reports.
Conclusion
: We suggest that prenatally buprenorphine-exposed children have several types of problems with their health at toddler age and that they are susceptible to child maltreatment, especially to medical neglect.
What is Known:
•
Buprenorphine is used in the treatment of opioid addiction in pregnancy. Prenatally buprenorphine-exposed newborns develop neonatal abstinence syndrome (NAS) in about 60 % of cases. Data on the health and maltreatment of these children after neonatal age are limited.
What is New:
•
Prenatally buprenorphine-exposed children can have several types of problems with their physical health by 3 years of age, and they are susceptible to child maltreatment, especially to medical neglect.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26003659</pmid><doi>10.1007/s00431-015-2562-0</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-6199 |
ispartof | European journal of pediatrics, 2015-11, Vol.174 (11), p.1525-1533 |
issn | 0340-6199 1432-1076 |
language | eng |
recordid | cdi_proquest_miscellaneous_1728258398 |
source | Springer Link |
subjects | Age Alcohol Analgesics, Opioid - adverse effects Buprenorphine - adverse effects Child Child abuse & neglect Child Abuse - diagnosis Child, Preschool Children & youth Congenital diseases Diabetes Drug abuse Female Finland - epidemiology Health Status Hepatitis B Hepatitis C Heroin Hospitals Humans Immune system Infant Infant, Newborn Infections Male Males Medical records Medicine Medicine & Public Health Methadone Mothers Narcotics Neonatal abstinence syndrome Original Article Pediatrics Pregnancy Prenatal Exposure Delayed Effects - chemically induced Prenatal Exposure Delayed Effects - epidemiology Prospective Studies SIDS Substance abuse treatment Sudden infant death syndrome Urine White people |
title | Prenatally buprenorphine-exposed children: health to 3 years of age |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A38%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prenatally%20buprenorphine-exposed%20children:%20health%20to%203%C2%A0years%20of%20age&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=Kivist%C3%B6,%20Kaisa&rft.date=2015-11-01&rft.volume=174&rft.issue=11&rft.spage=1525&rft.epage=1533&rft.pages=1525-1533&rft.issn=0340-6199&rft.eissn=1432-1076&rft_id=info:doi/10.1007/s00431-015-2562-0&rft_dat=%3Cproquest_cross%3E1728258398%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c405t-c701b82459fe12b5bb12e90c029819972a4e8eacdd2cbf2e2da67cce33e682b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1727593807&rft_id=info:pmid/26003659&rfr_iscdi=true |